Quantcast
Last updated on April 17, 2014 at 8:59 EDT

Latest Full genome sequencing Stories

2013-10-07 08:25:29

NEW YORK, October 7, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Illumina, Inc. (NASDAQ: ILMN), and Intrexon Corporation (NYSE: XON). Today's readers may access these reports free of charge - including full...

2013-10-04 23:18:48

On Wednesday, October 16, 2013 at 12:00pm EDT, Xtalks will be hosting a live webinar on sequence capture technology for genotyping by sequencing for wheat, barley and maize. Toronto, Canada (PRWEB) October 04, 2013 Join esteemed speakers from Iowa State University, Kansas State University and Leibniz Institute of Plant Genetics and Crop Plant Resaerch (IPK), as they share their research including a case study of how custom target enrichment from Roche NimbleGen is enabling plant genomics...

2013-10-04 13:13:15

How do the millions of genetic variants - ranging in size from a change in a single nucleotide (the As,Ts,Cs and Gs that define the genetic alphabet) to huge rearrangements of chromosomes that can affect many different genes - found in each human chromosome affect the health, longevity and lives of people? In a major report in the journal Science, an international consortium of groups that includes the Baylor College of Medicine Human Genome Sequencing Center describe an analytical approach...

2013-10-04 12:23:19

DUBLIN, Ireland, October 4, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cvknrc/global_dna) has announced the addition of the "Global DNA Sequencing Equipment and Services Market 2012-2016" [http://www.researchandmarkets.com/research/cvknrc/global_dna ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global DNA Sequencing Equipment and Services market to...

2013-10-03 16:09:36

Psychiatrist, geneticist, neurosurgeon and genome sequencers generate data on one patient,with big implications for care A multidisciplinary team led by a geneticist and psychiatrist from Cold Spring Harbor Laboratory's (CSHL) Stanley Institute for Cognitive Genomics today publish a paper providing a glimpse of both the tremendous power and the current limitations of what is sometimes called "precision medicine." Precision medicine is an approach to diagnosis and treatment that tailors...

2013-10-02 23:22:13

Reportbuyer.com just published a new market research report: Genetic Testing Market Outlook to 2017. London (PRWEB) October 02, 2013 A recent report, “Genetic Testing Market Outlook to 2017”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing...

2013-10-02 23:17:50

Despite the adoption of next-generation DNA sequencing (NGS) systems, Kalorama Information says that older capillary DNA sequencing systems remain in labs and are used consistently. More than one out of every four sequencers owned by labs surveyed is still a Sanger or capillary type system, and almost all are made by Life Technologies / Applied Biosystems. New York (PRWEB) October 02, 2013 Despite the adoption of next-generation DNA sequencing (NGS) systems, Kalorama Information says that...

2013-09-30 10:17:55

As so many genome studies do, this study published online in the journal Nature Genetics began with a single patient and his parents who were in search of a diagnosis. The parents of this first patient sought genetic testing for Prader-Willi syndrome when he was only a year old, but the test, which was still in its infancy, came back negative. For the next 12 years, his parents were left in limbo. He had many features of the disease – including lack of muscle tone, feeding difficulties...

2013-09-26 13:13:17

As gene sequencing technologies rapidly advance and new genomic data becomes available, so does the need for a better understanding and consensus on which gene changes are relevant to diagnosis and treatment. With a $8.4 million, four-year grant announced today from the National Human Genome Research Institute, researchers from Baylor College of Medicine and The Stanford University School of Medicine hope to address this need by creating a central resource. "The Stanford/Baylor effort...

2013-09-25 08:29:33

G3's Cardiovascular Disease Biomarker and Drug Target Discovery Study (the "GLOBAL" Study) is the Single Largest Prospective Pan-Omic Study to Employ Whole Genome Sequencing RICHMOND, Va., and SAN DIEGO, Sept. 25, 2013 /PRNewswire/ -- Global Genomics Group (G3) and Illumina, Inc. (NASDAQ: ILMN) today announced that they have entered into a partnership to investigate novel biomarkers and biological pathways involved in the development and diagnosis of cardiovascular diseases. Under...